Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 8
Submit an article Journal homepage
693
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma

Rebecca L. ElstromCenter for Lymphoma and Myeloma
,
Biree AndemariamCenter for Lymphoma and Myeloma; *Lea Center for Hematologic Disorders, University of Connecticut Health Center, Farmington, CT, USA
,
Peter MartinCenter for Lymphoma and Myeloma
,
Jia RuanCenter for Lymphoma and Myeloma
,
Tsiporah B. ShoreBone Marrow Transplant Program, Weill Cornell Medical College, New York, NY, USA
,
Morton ColemanCenter for Lymphoma and Myeloma
,
John P. LeonardCenter for Lymphoma and Myeloma
&
Richard R. FurmanCenter for Lymphoma and MyelomaCorrespondence[email protected]
 show all
Pages 1469-1473 | Received 10 Nov 2011, Accepted 06 Jun 2012, Published online: 20 Jan 2012

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ercan Cacan & Zeliha C. Ozmen. (2020) Regulation of Fas in response to bortezomib and epirubicin in colorectal cancer cells. Journal of Chemotherapy 32:4, pages 193-201.
Read now
Prithviraj Bose, Michael S Batalo, Beata Holkova & Steven Grant. (2014) Bortezomib for the treatment of non-Hodgkin’s lymphoma. Expert Opinion on Pharmacotherapy 15:16, pages 2443-2459.
Read now

Articles from other publishers (18)

Ye Yao, Qing-yu Yao, Jun-sheng Xue, Xiu-yun Tian, Qi-ming An, Li-xuan Cui, Chang Xu, Hong Su, Liang Yang, Yao-yao Feng, Chun-yi Hao & Tian-yan Zhou. (2020) Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor. Toxicology and Applied Pharmacology 401, pages 115118.
Crossref
Feifei Sun, Xiaosheng Fang & Xin Wang. (2020) Signal Pathways and Therapeutic Prospects of Diffuse Large B Cell Lymphoma. Anti-Cancer Agents in Medicinal Chemistry 19:17, pages 2047-2059.
Crossref
Ana C. Henriques, Diana Ribeiro, Joel Pedrosa, Bruno Sarmento, Patrícia M.A. Silva & Hassan Bousbaa. (2019) Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution. Cancer Letters 440-441, pages 64-81.
Crossref
Yun Liu, Wen-Jing Huang, Min-Ting Lin, Jia-Jun Li & Jian-Ye Zhang. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy 207 228 .
Ruihuan Wang, Jie Shen, Qing Wang & Minjuan Zhang. (2018) Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198. Biomedicine & Pharmacotherapy 108, pages 43-49.
Crossref
John P. LeonardKathryn S. KolibabaJames A. ReevesAnil TulpuleIan W. FlinnTatjana KolevskaRobert RoblesChristopher R. FlowersRobert CollinsNicholas J. DiBellaSteven W. PapishParameswaran VenugopalAndrew HorodnerAmir TabatabaiJulio HajdenbergJaehong ParkRachel NeuwirthGeorge MulliganKaveri SuryanarayanDixie-Lee EsseltineSven de Vos. (2017) Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology 35:31, pages 3538-3546.
Crossref
Allison M. WinterDaniel J. LandsburgAnthony R. MatoKrista IsaacFrancisco J. Hernandez-IlizaliturriNishitha ReddyStephen SmithMazyar ShadmanMitchell R. Smith, Paolo Caimi, Deepa JagadeeshBrian T. Hill. (2017) A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib. Blood 130:14, pages 1676-1679.
Crossref
Gilles Salles, Martin Barrett, Robin Foà, Joerg Maurer, Susan O’Brien, Nancy Valente, Michael Wenger & David G. Maloney. (2017) Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience. Advances in Therapy 34:10, pages 2232-2273.
Crossref
Mariano Provencio, Marta Rodríguez, Blanca Cantos, Pilar Sabín, Cristina Quero, Francisco R. García-Arroyo, Antonio Rueda, Constanza Maximiano, Delvys Rodríguez-Abreu, Antonio Sánchez, Javier Silva & Vanesa García. (2017) mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish Lymphoma Oncology Group. Oncotarget 8:31, pages 50949-50957.
Crossref
Morton Coleman, Philip E. Lammers, Fabio Ciceri & Ira A. Jacobs. (2016) Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 16:4, pages 175-181.
Crossref
Fritz OffnerOlga SamoilovaEvgenii OsmanovHyeon-Seok EomMax S. ToppJoão RaposoViacheslav PavlovDeborah RicciShalini ChaturvediEugene ZhuHelgi van de Velde, Christopher EnnyAleksandra RizoBurhan Ferhanoglu. (2015) Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL. Blood 126:16, pages 1893-1901.
Crossref
Ping Zhou, Peng Liu, Sheng-Yu Zhou, Xiao-Hui He, Xiao-Hong Han, Yan Qin, Sheng Yang, Chang-Gong Zhang, Lin Gui, Jia-Rui Yao, Li-Ya Zhao, Shu-Xiang Zhang, Yan Sun & Yuan-Kai Shi. (2015) Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas. Chinese Medical Journal 128:18, pages 2498-2504.
Crossref
Chen-Ge Song, Jia-Jia Huang, Ya-Jun Li, Yi Xia, Yu Wang, Xi-Wen Bi, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin & Zhi-Ming Li. (2015) Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis. PLOS ONE 10:7, pages e0133973.
Crossref
Francesca Merchionne, Giovanni Quintana, Francesco Gaudio, Carla Minoia, Giorgina Specchia, Attilio Guarini, Giovanni Quarta, Vincenzo Pavone & Angela Melpignano. (2014) Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis. Leukemia Research 38:12, pages 1446-1450.
Crossref
Corrado Tarella, Angela Gueli, Federica Delaini, Andrea Rossi, Anna Maria Barbui, Giuseppe Gritti, Cristina Boschini, Daniele Caracciolo, Riccardo Bruna, Marco Ruella, Daniela Gottardi, Roberto Passera & Alessandro Rambaldi. (2014) Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin’s Lymphoma: Correlation with Long-Term Survival. PLoS ONE 9:9, pages e106745.
Crossref
Maurizio Martelli, Andrés J.M. Ferreri, Claudio Agostinelli, Alice Di Rocco, Michael Pfreundschuh & Stefano A. Pileri. (2013) Diffuse large B-cell lymphoma. Critical Reviews in Oncology/Hematology 87:2, pages 146-171.
Crossref
Matthew J. MatasarMyron S. CzuczmanMaria Alma RodriguezMichael FennessyThomas C. SheaGary SpitzerIzidore S. LossosMohamed A. Kharfan-DabajaRobin JoyceLuis FayadKristen HenkelQiming LiaoKlaus EdvardsenRoxanne C. JewellDoug FecteauRajendra P. Singh, Steen Lisby & Craig H. Moskowitz. (2013) Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma. Blood 122:4, pages 499-506.
Crossref
Zhixin Li. (2013) Ammonium chloride enhances cisplatin cytotoxicity through DNA double-strand breaks in human cervical cancer cells. Oncology Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.